Wuhan Healthgen Biotechnology Corp. (SHA:688765)

SHA:688765 Revenue

Wuhan Healthgen Biotechnology had revenue of 9.53M CNY in the half year ending June 30, 2024, with 441.68% growth. This brings the company's revenue in the last twelve months to 28.39M, up 17.02% year-over-year. In the year 2024, Wuhan Healthgen Biotechnology had annual revenue of 25.22M with 3.92% growth.

• Revenue (ttm): 28.39M
• Revenue Growth: +17.02%
• P/S Ratio: 989.41
• Revenue / Employee: 179.70K
• Employees: 158
• Market Cap: 28.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	25.22M	951.94K	3.92%
Dec 31, 2023	24.26M	10.86M	81.08%
Dec 31, 2022	13.40M	-12.12M	-47.49%
Dec 31, 2021	25.52M	3.95M	18.33%
Dec 31, 2020	21.57M	11.32M	110.40%